MCK
stock Healthcare Medical DistributionOverall Healthy · 70%
- Fundamentals Fair
- Trajectory Climbing
- Leadership Stable
A read across fundamentals, recent price & growth trajectory, and leadership stability. For fun and reading at a glance, not investment advice.
What the indicators say
Bearish 0 of 5 trend signals bullishRSI 36 — soft momentum, not yet oversold.
A mechanical reading of the chart’s indicators — not investment advice.
Key statsas of Jun 3
- Open
- $739.95
- +0.43%
- Close
- $739.95
- +0.43%
- Current
- $739.95
- Prev close
- $736.78
- Today
- 556.83K
- 3-mo avg
- 1.00M
Earningscalendar synced from Yahoo 57d ago
- Most recent
- May 775 days ago
- Next expected
- Aug 5in 15 days
Recent earnings dates
- May 7 75 days ago
- Feb 4 167 days ago
- Nov 5, 2025 258 days ago
- Sep 18, 2025 306 days ago
Past earnings dates come from MCK’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.
Fundamentalssynced from SEC 51d ago
Across the nine graded ratios (FY2026 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), MCK’s fundamentals read as fair overall.
At 19.3x, the price is a reasonable multiple of the company's annual profit.
Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.
A 0.4% yield is modest: a small income on top of whatever the share price does.
The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.
A 1.2% margin is thin; little of each revenue dollar survives as profit.
The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.
Shareholder equity is negative, so return on equity is not meaningful.
Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.
A 5.8% return on assets is reasonable for a company of this kind.
Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.
Not enough data to compute debt-to-equity.
Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.
At 0.85, short-term assets fall short of short-term bills; liquidity is tight.
Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.
Revenue grew 12.4% from the prior year: strong top-line expansion.
Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.
Net income grew 44.5% from the prior year: strong profit expansion.
Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.
Financialssynced from SEC 51d ago
| FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | |
|---|---|---|---|---|---|
| Revenue | $264.0B | $276.7B | $309.0B | $359.1B | $403.4B |
| Net income | $1.1B | $3.6B | $3.0B | $3.3B | $4.8B |
| Diluted EPS | $7.23 | $25.03 | $22.39 | $25.72 | $38.38 |
| Dividend / share | $1.83 | $2.09 | $2.40 | $2.75 | $3.17 |
| Total assets | $63.3B | $62.3B | $67.4B | $75.1B | $82.3B |
| Total liabilities | — | — | — | — | — |
| Shareholder equity | -$1.8B | -$1.5B | -$1.6B | -$2.1B | -$2.2B |
| Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 | Q1-2026 | Q2-2026 | Q3-2026 | Q4-2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $79.3B | $93.7B | $95.3B | $90.8B | $97.8B | $103.2B | $106.2B | $96.3B |
| Net income | $915.0M | $241.0M | $879.0M | $1.3B | $784.0M | $1.1B | $1.2B | $1.7B |
| Diluted EPS | $7.00 | $1.87 | $6.95 | $9.90 | $6.25 | $8.92 | $9.59 | $13.62 |
| Dividend / share | $0.62 | $0.71 | $0.71 | $0.71 | $0.71 | $0.71 | $0.71 | $1.04 |
Leadershipsynced from SEC 55d ago
- Tyler Brian S. Chief Executive Officer · Director
- Vitalone Britt J. EVP & CFO
- Fraga Francisco EVP, CIO and CTO
- Lau Michele EVP and Chief Legal Officer
- Rodgers Thomas L EVP, Chief Strategy & BDO
- Rutledge Napoleon B Jr SVP, Controller & CAO
- Smith Leann B EVP & Chief HR Officer
Officers and board are drawn from MCK’s recent SEC ownership filings (Forms 3, 4 and 5).
Recent leadership changes
Notable recent eventspast year
- May 6 New 6-month low (-25% off peak)
- May 6 −7.2% one-day move
- Mar 31 FY2026 net income +45% YoY
- Mar 5 Officer or director change reported in an 8-K
- Feb 5 +16.5% one-day move
- Sep 23, 2025 +6.4% one-day move
- Aug 7, 2025 −5.8% one-day move
Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.
Dividendssynced from Yahoo 52d ago
- 2025 total
- $3.06
- 2026 so far
- $0.821 payment
- 2026 projected
- $3.28+7.2% vs 2025
Projection scales MCK’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.
Payment history
- Mar 2 $0.82
- Dec 1, 2025 $0.82
- Sep 2, 2025 $0.82
- Jun 2, 2025 $0.71
- Mar 3, 2025 $0.71
- Dec 2, 2024 $0.71
- Aug 30, 2024 $0.71
- Jun 3, 2024 $0.62
- Feb 29, 2024 $0.62
- Nov 30, 2023 $0.62
- Aug 31, 2023 $0.62
- May 31, 2023 $0.54
- Feb 28, 2023 $0.54
- Nov 30, 2022 $0.54
- Aug 31, 2022 $0.54
- May 31, 2022 $0.47
- Feb 28, 2022 $0.47
- Nov 30, 2021 $0.47
- Aug 31, 2021 $0.47
Recent SEC filingssynced from SEC 51d ago
- 10-K Annual report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- 8-K Current report
- 10-Q Quarterly report
- 8-K Current report
- 8-K Current report
- DEF 14A Proxy statement
- 8-K Current report
- 8-K Current report